Revvity Inc. Common Stock (RVTY)
Stock · NYSE · Industrials
$152.64as of 10/16/2026
Price chart
Active signals
RVTY Signal Track Record
How signals performed across all stocks →What RVTY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -3.0% | 37% | September 30, 2026 |
| Bollinger Band Breakout | 27 | -1.1% | 41% | September 15, 2026 |
| Bollinger Band Breakdown | 21 | -1.1% | 43% | April 29, 2026 |
| 200-Day Moving Average TouchActive now | 20 | -2.6% | 30% | May 13, 2026 |
| Any 20-session window (baseline) | -0.1% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About RVTY
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease te…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 11,000
- Website
- www.revvity.com/
Fundamentals
- 1-day range
- $153.46$156.3
- Market cap
- $12.74B
- P/E (trailing)
- 72.12
- P/E (forward)
- 26.43
- EPS (trailing)
- $2.10
- Dividend yield
- 0.31%
- Beta
- 1.09
- Avg. volume
- 1.79M
- Ex-dividend date
- October 23, 2026
- Dividend pay date
- November 13, 2026
How Revvity Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Revvity Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- RVTYRevvity Inc. Common Stock$152.64▼ 1.34%Market cap $12.74BP/E 72.12$81.22$166.25
- BIOBio-Rad Laboratories Inc. Class A Common Stock$353.7▼ 3.05%Market cap $9.16BP/E 43.88$236.73$396.23
- AVTRAvantor Inc. Common Stock$16.42▲ 2.05%Market cap $8.91BP/E —$7.27$16.38
- BRKRBruker Corporation Common Stock$54.8▼ 3.08%Market cap $7.95BP/E —$32.37$66.98
- TXG10x Genomics Inc. Class A Common Stock$69.86▼ 3.49%Market cap $5.79BP/E —$11.62$102.81
- EYPTEyePoint Inc. Common Stock$2.99▼ 4.78%Market cap $1.08BP/E —$2.93$19.11
- CTKBCytek Biosciences Inc. Common Stock$5.25▼ 2.96%Market cap $537.23MP/E —$3.31$6.21
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RVTY Revvity Inc. Common Stock | $12.74B | 72.12 | $152.64 | ▼ 1.34% | $81.22$166.25 |
| BIO Bio-Rad Laboratories Inc. Class A Common Stock | $9.16B | 43.88 | $353.7 | ▼ 3.05% | $236.73$396.23 |
| AVTR Avantor Inc. Common Stock | $8.91B | — | $16.42 | ▲ 2.05% | $7.27$16.38 |
| BRKR Bruker Corporation Common Stock | $7.95B | — | $54.8 | ▼ 3.08% | $32.37$66.98 |
| TXG 10x Genomics Inc. Class A Common Stock | $5.79B | — | $69.86 | ▼ 3.49% | $11.62$102.81 |
| EYPT EyePoint Inc. Common Stock | $1.08B | — | $2.99 | ▼ 4.78% | $2.93$19.11 |
| CTKB Cytek Biosciences Inc. Common Stock | $537.23M | — | $5.25 | ▼ 2.96% | $3.31$6.21 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Which S&P500 stocks are gapping on Thursday?ChartMill · 10/8/2026
- Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key PlayersYahoo · 10/7/2026
- Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160Benzinga · 10/7/2026
- Revvity Earnings Preview: What to ExpectYahoo · 10/7/2026
- William Blair Initiates Coverage On Revvity with Outperform RatingBenzinga · 10/6/2026
- Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%Benzinga · 10/6/2026
- Revvity to Host Investor DayYahoo · 10/6/2026
- Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?Yahoo · 10/2/2026
Insider Activity
Insider Actions →- Anita Gonzales · October 1, 2026 · Sale84 @ $155.48
- Maxwell Krakowiak · September 21, 2026 · Sale1.6K @ $144.53
- Tajinder S. Vohra · September 16, 2026 · Sale7.3K @ $140.88
- Alexis P. Michas · August 25, 2026 · Gift285
- Joel S. Goldberg · August 14, 2026 · Gift27.8K
- Prahlad R. Singh · August 13, 2026 · Gift59.6K
- Prahlad R. Singh · August 13, 2026 · Gift7.6K
- Anita Gonzales · July 20, 2026 · Sale85 @ $109.48
- Michelle McMurry-Heath · May 7, 2026 · Grant1.3K
- Michelle McMurry-Heath · May 7, 2026 · Grant1.0K
- Pascale Witz · May 7, 2026 · Grant1.0K
- Samuel R. Chapin · May 7, 2026 · Grant1.3K
- Peter Barrett · May 7, 2026 · Grant1.0K
- Alexis P. Michas · May 7, 2026 · Grant1.5K
- Alexis P. Michas · May 7, 2026 · Grant1.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 110.08M
- Total value held
- $6.77B
- Institutional holders
- 494
- Unknown22.20M
- Unknown10.09M
- Unknown8.80M
- Unknown8.35M
- Unknown7.33M
- Unknown7.25M
- Unknown4.31M
- Unknown3.37M
- Unknown2.94M
- Unknown2.92M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Revvity Announces Earnings Call, Analysts Upgrade Rating
Revvity has announced that it will conduct an earnings call on November 3, 2026. Analysts have upgraded the stock’s rating, citing stronger fundamentals and a positive outlook. Today’s trading saw unusual volume and the price is near its support level of $110.97 with an RSI of 68.9, indicating a moderately overbought condition.
Revvity Announces Earnings Call, Analysts Upgrade Rating. Revvity has announced that it will conduct an earnings call on November 3, 2026. Analysts have upgraded the stock’s rating, citing stronger fundamentals and a positive outlook. Today’s trading saw unusual volume and the price is near its support level of $110.97 with an RSI of 68.9, indicating a moderately overbought condition.